Mutations in the epidermal growth factor receptor (EGFR) gene are commonly observed in
non-small-cell lung cancer (NSCLC), particularly in tumors of adenocarcinoma (ADC) …

Background Identification of variable epidermal growth factor receptor (EGFR) gene
mutations in non-small cell lung cancer (NSCLC) is important for the selection of appropriate …

Background Prevention, control, and treatment of respiratory tract cancers are important
steps towards achieving target 3.4 of the UN Sustainable Development Goals (SDGs)—a …

Osierdzie (z greckiego veri—wokół, kardiou—serce) stanowi zbudowaną z dwóch blaszek
workowatą strukturę, w której znajduje się serce i wychodzące z niego duże pnie …

Lung cancer is the leading cause of death for malignancy worldwide. Its molecular profiling
has enriched our understanding of cancer initiation and progression and has become …

Lung cancer is the leading cause of cancer-related mortality. While the majority of lung
cancers are associated with tobacco smoke, approximately 10–15% of US lung cancers …

Aims Activating mutations in the gene encoding epidermal growth factor receptor (EGFR)
can confer sensitivity to EGFR tyrosine kinase inhibitors such as gefitinib in patients with …

Objectives Non-small cell lung cancer (NSCLC) is a heterogeneous disease with unique
combinations of somatic molecular alterations in individual patients, as well as significant …

Ethnic and geographic differences in cancer incidence, prognosis, and treatment outcomes
can be attributed to diversity in the inherited (germline) and somatic genome. Although …

Background: Determining the somatic mutations of epidermal growth factor receptor (EGFR)-
pathway networks is the key to effective treatment for non-small cell lung cancer (NSCLC) …